Posts

Drug market trends of cocaine, ATS and NPS: 2022

Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS. Read more

Connectomics Reveals Role of Dopamine in Cocaine Addiction

Researchers have used advanced technology and mice to study dopamine neuron structure, addiction and the brain’s ability to recover. Read more

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in Canada

For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine (pharmaceutical grade heroin). While this treatment is effective at reducing illicit opioid use, concurrent cocaine use is prevalent. Dextroamphetamine (a central nervous system stimulant) has been found to be a safe and effective treatment for cocaine dependence among people receiving injectable opioid agonist treatment in Europe. Read more